Tg Therapeutics reported $142K in Ordinary Share Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Amgen AMGN:US $ 31877M 71M
Ardelyx ARDX:US $ 0.01M 0M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Arrowhead Research ARWR:US $ 197K 1000
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Corcept Therapeutics CORT:US $ 0.12M 0M
Curis CRIS:US $ 0.92M 0M
Dynavax Technologies DVAX:US $ 0.11M 0M
Infinity Pharmaceuticals INFI:US $ 0.09M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Novartis NOVN:VX SF 913M 0M
Novavax NVAX:US $ 0.75M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Spectrum Pharmaceuticals SPPI:US $ 0.16M 0.01M
Verastem VSTM:US $ 0.02M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M
Ziopharm Oncology ZIOP:US $ 0.22M 0M